Dianthus Therapeutics
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $100M
Investors
- 7
About Dianthus Therapeutics
Founded in 2019 and based in Massachusetts, US, Dianthus Therapeutics, Inc. is a biotechnology firm that focuses on the development of antibody therapeutics and pharmaceuticals. In April 2022, Dianthus Therapeutics, Inc. As of 2022, Marino Garcia is the CEO of the company. The company designs and delivers monoclonal antibodies with selectivity and potency over existing complement therapies. The firm is developing DNTH103, a monoclonal antibody that targets the active form of complement C1s, allowing for a lower dosage volume and less frequent subcutaneous administration, which is further strengthened by half-life extension technology. Dianthus also develops DNTH200 and DNTH300.
Who invested in Dianthus Therapeutics
7 investors across 1 round
See all investors in Dianthus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 6, 2022
Amount
$100M
Investors
Questions about Dianthus Therapeutics
Who invested in Dianthus Therapeutics?
Dianthus Therapeutics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dianthus Therapeutics raised?
Dianthus Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dianthus Therapeutics last raise money?
Dianthus Therapeutics's most recent round on record is a Series A, in Apr 2022.
What does Dianthus Therapeutics do?
Founded in 2019 and based in Massachusetts, US, Dianthus Therapeutics, Inc.
Where is Dianthus Therapeutics headquartered?
Dianthus Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Dianthus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dianthus Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Dianthus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.